The global mineral supplements market size accounted for US$ 16.53 billion in 2023 and is projected to reach around USD 29.66 billion by 2033, growing at a CAGR of 6.02% from 2024 to 2033.
Key Points
- Asia-Pacific dominated the market with the largest market share of 40% in 2023.
- By product, the calcium segment has contributed the largest market share of 42% in 2023.
- By formulation, the tablet segment led the market with the biggest market share of 36% in 2023.
- By application, the general health segment has led the major market share of 41% in 2023.
- By end-use, the adult segment has accounted more than 48% of market share in 2023.
- By sales channel, the pharmacies & drug stores segment dominated the market in 2023.
Report Summary
The global mineral supplements market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the mineral supplements market across the globe.
A comprehensive estimate on the mineral supplements market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of mineral supplements during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3885
Mineral Supplements Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.02% |
| Global Market Size in 2023 | USD 16.53 Billion |
| Global Market Size by 2033 | USD 29.66 Billion |
| Largest Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Formulation, By Application, By End-Use, and By Sales Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized mineral supplements market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Hearing Loss Disease Treatment Market Size, Growth, Report 2033
Market Players
The report includes the profiles of key mineral supplements market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In September 2023, Sanofi declared the successful conclusion of its acquisition of Qunol, the top-ranking health and wellness brand in the United States market. With a focus on the active “healthy aging” market, this transaction enhances Sanofi’s Consumer Healthcare’s (CHC) Vitamin, Mineral, & Supplements (VMS) category, which is among the largest and most rapidly expanding consumer health segments in the United States.
Mineral Supplements Market Companies
- Glanbia, plc.
- Abbott
- Nestle
- Biovea
- Herbalife International of America, Inc.
- Sanofi
- Amway
- Bayer AG
- Omega Protein Corporation
- Bio Botanica, Inc.
- Pharmavite LLC
- DSM
- Nu Skin
Segments Covered in the Report
By Product
- Calcium
- Magnesium
- Iron
- Potassium
- Zinc
- Chromium
- Selenium
- Others
By Formulation
- Capsule
- Tablet
- Powder
- Liquid/Gel
- Others
By Application
- General Health
- Bone & Joint Health
- Gastrointestinal Health
- Immunity
- Others
By End-Use
- Adults
- Geriatric
- Pregnant Women
- Children
- Infants
By Sales Channel
- Pharmacies & Drug Stores
- Supermarkets & Hypermarkets
- Online Channels
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Mineral Supplements Market
5.1. COVID-19 Landscape: Mineral Supplements Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Mineral Supplements Market, By Product
8.1. Mineral Supplements Market Revenue and Volume, by Product, 2024-2033
8.1.1. Calcium
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Magnesium
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Iron
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Potassium
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Zinc
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
8.1.6. Chromium
8.1.6.1. Market Revenue and Volume Forecast (2021-2033)
8.1.7. Selenium
8.1.7.1. Market Revenue and Volume Forecast (2021-2033)
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Mineral Supplements Market, By Formulation
9.1. Mineral Supplements Market Revenue and Volume, by Formulation, 2024-2033
9.1.1. Capsule
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Dessert
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Powder
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Liquid/Gel
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Others
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Mineral Supplements Market, By Application
10.1. Mineral Supplements Market Revenue and Volume, by Application, 2024-2033
10.1.1. General Health
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Bone & Joint Health
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Gastrointestinal Health
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Immunity
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Mineral Supplements Market, By End-Use
11.1. Mineral Supplements Market Revenue and Volume, by End-Use, 2024-2033
11.1.1. Adults
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Geriatric
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Pregnant Women
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1.4. Children
11.1.4.1. Market Revenue and Volume Forecast (2021-2033)
11.1.5. Infants
11.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Mineral Supplements Market, By Sales Channel
12.1. Mineral Supplements Market Revenue and Volume, by Sales Channel, 2024-2033
12.1.1. Pharmacies & Drug Stores
12.1.1.1. Market Revenue and Volume Forecast (2021-2033)
12.1.2. Supermarkets & Hypermarkets
12.1.2.1. Market Revenue and Volume Forecast (2021-2033)
12.1.3. Online Channels
12.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 13. Global Mineral Supplements Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.6.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.1.7.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.1.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.1.7.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.1.7.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.7. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.8. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.9.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.9.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.10. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.11. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.12.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.12.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.12.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.13. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.2.14.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.2.14.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.2.14.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.2.15. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.3.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.3.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.3.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.3.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.9. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.10.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.10.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.10.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.10.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.4.11.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.4.11.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.4.11.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.4.11.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.6.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.6.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.7. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)
13.5.8.2. Market Revenue and Volume Forecast, by Formulation (2021-2033)
13.5.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
13.5.8.4. Market Revenue and Volume Forecast, by End-Use (2021-2033)
13.5.8.5. Market Revenue and Volume Forecast, by Sales Channel (2021-2033)
Chapter 14. Company Profiles
14.1. Glanbia, plc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Nestle
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Biovea
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Herbalife International of America, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Sanofi
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Amway
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Bayer AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Omega Protein Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Bio Botanica, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
